| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.29 | 1e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.33 | 7e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.35 | 4e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.35 | 6e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.37 | 5e-09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.44 | 2e-10 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.32 | 0.3 |